Pfizer Inc. (NYSE:PFE) is a company that manufactures and markets biopharmaceutical products worldwide. They provide medications for various conditions including heart disease, diabetes mellitus type 2, viral infections such as those caused by influenza A virus subtype H1N1 or enteroviruses, and cancer treatments involving chemotherapy agents.
Pfizer also provides vaccines against bacterial pneumonia, meningococcal diseases, Covid 19, strep throat among others. The company is a leader in contract manufacturing. They provide services to wholesalers, hospitals, retailers, disease prevention and control centres, and government agencies.
Medical Properties Trust Inc
Medical Properties Trust, Inc. (NYSE:MPW) is a real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. The company has grown gradually to become one of the world’s largest owners, with approximately 431 hospitals across nine countries in four continents.
This growth can be attributed largely due to their financing model which facilitates purchases or recapitalizations while also allowing operators to unlock the value buried within these properties so they may spend money wisely for improvements like technology upgrades but most importantly investing heavily into operations!
Which one is a better buy?
Pfizer and Medical Properties are both awesome buys at current prices. They are both in markets that tend to perform well regardless of market conditions. Now that rates are going up, these two make for good defensive stocks.
However, of the two, Pfizer makes for a better buy. That’s because the COVID-19 vaccine has given Pfizer not just a boost in revenues. Pfizer is also one of the world’s largest pharmaceutical companies and always a product in the pipeline. This pretty much guarantees its revenue growth not just in 2022 but for years to come.
The post Pfizer v Medical Properties: Covid-19 Vaccines give Pfizer an edge appeared first on Invezz.